SCHEMBL2847136

SCHEMBL2847136

CCOC(=O)C(=O)C1COCC(=Cc2ccc(F)cc2)C1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.47
ALDH1A1 P00352 4/20 0.47
CYP1A2 P05177 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
LMNA P02545 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
STAT3 P40763 1/20 0.39
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
PTGS2 P35354 1/20 0.38
AKR1B1 P15121 1/20 0.36
HSD11B1 P28845 1/20 0.36
KDM4E B2RXH2 2/20 0.36
TP53 P04637 1/20 0.36
HPGD P15428 1/20 0.36
GAA P10253 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13411537 1.00 MAPT (0.47) MAPTALDH1A1CYP1A2MEN1KMT2A
SCHEMBL645065 0.83 ALDH1A1 (0.48) MAPTALDH1A1CYP1A2MEN1KMT2A
SCHEMBL645064 0.83 ALDH1A1 (0.48) MAPTALDH1A1CYP1A2MEN1KMT2A
SCHEMBL182255 0.81 ALDH1A1 (0.46) MAPTALDH1A1CYP1A2MEN1KMT2A
SCHEMBL2719545 0.81 ALDH1A1 (0.46) MAPTALDH1A1CYP1A2MEN1KMT2A
SCHEMBL182254 0.81 ALDH1A1 (0.46) MAPTALDH1A1CYP1A2MEN1KMT2A
SCHEMBL176973 0.80 NPC1 (0.48) MAPTALDH1A1CYP1A2MEN1KMT2A
SCHEMBL13867288 0.80 MAPT (0.45) MAPTALDH1A1CYP1A2MEN1KMT2A
SCHEMBL13745233 0.80 NPC1 (0.48) MAPTALDH1A1CYP1A2MEN1KMT2A
SCHEMBL3886895 0.80 MAPT (0.45) MAPTALDH1A1CYP1A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100069341-A1 TETRAHYDRO-PYRANOPYRAZOLE CANNABINOID MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2010-03-18 US disclosed
US-20070155723-A1 Tetrahydro-pyranopyrazole cannabinoid modulators JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-05 US disclosed
WO-2007001939-A1 TETRAHYDRO-PYRANOPYRAZOLE COMPOUNDS DISPLAYING CANNABINOID MODULATING ACTIVITIES JANSSEN PHARMACEUTICA N.V. (BE) 2007-01-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155723-A1 Tetrahydro-pyranopyrazole cannabinoid modulators CNR2, CNR1, GPR18 MAPT 1557/4885ALDH1A1 1987/4885CYP1A2 387/4885
US-20100069341-A1 TETRAHYDRO-PYRANOPYRAZOLE CANNABINOID MODULATORS CNR2, CNR1, GPR18 MAPT 1557/4885ALDH1A1 1987/4885CYP1A2 387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.